Showing 21 - 40 results of 4,510 for search '"positron emission tomography"', query time: 0.41s Refine Results
  1. 21

    POSITRON EMISSION TOMOGRAPHY (PET) IN BREAST CANCER DIAGNOSIS by Haluk Burçak Sayman

    Published 2009-04-01
    “…In this respect, nuclear medicine extended its useful contributions by scintimammography after the use of specific substances such as Tc-99m MIBI and further improved with the Positron Emission Tomography. In this review the benefits of PET in the diagnosis of breast cancer and its methods are reported…”
    Get full text
    Article
  2. 22
  3. 23
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29
  10. 30

    Positron Emission Tomography Probes for Imaging Cytotoxic Immune Cells by Ala Amgheib, Ruisi Fu, Eric O. Aboagye

    Published 2022-09-01
    “…Non-invasive positron emission tomography (PET) imaging of immune cells is a powerful approach for monitoring the dynamics of immune cells in response to immunotherapy. …”
    Get full text
    Article
  11. 31

    Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography by Ruth González-Gómez, Roberto A. Pazo-Cid, Luis Sarría, Miguel Ángel Morcillo, Alberto J. Schuhmacher

    Published 2021-03-01
    “…“Immuno-PET” merges the high target selectivity and specificity of antibodies and engineered fragments toward a given tumor cell surface marker with the high spatial resolution, sensitivity, and quantitative capabilities of positron emission tomography (PET) imaging techniques. In this review, we detail and provide examples of the clinical limitations of current imaging techniques for diagnosing PDAC. …”
    Get full text
    Article
  12. 32
  13. 33

    Dose absorbed by technologists in positron emission tomography procedures with FDG by Ademir Amaral, Christian Itié, Bernard Bok

    Published 2007-09-01
    “…The objective of this work was to evaluate radiation doses delivered to technologists engaged in different tasks involving positron emission tomography (PET) studies with FDG (fluorodeoxyglucose). …”
    Get full text
    Article
  14. 34

    Hygienic requirements to the design of the positron-emission tomography centers and departments by O. V. Minonenko, T. B. Baltrukova, N. S. Bashketova, G. A. Gorskiy, T. V. Kryukova, E. A. Fedorova

    Published 2019-06-01
    “…It was determined, that, despite the existence of the actual direct action document (SanPiN2.6.1.3288-15 “Hygienic requirements on the provision of the radiation safety for the preparation and performance of the positron emission tomography”, it is necessary to consider the hygienic requirements from other legislative documents, hence complicating the process of design and project approval. …”
    Get full text
    Article
  15. 35
  16. 36

    Positron emission tomography: Evolving modalities, radiopharmaceuticals and professional collaboration by Sally L. Ayesa, Andrew Murphy

    Published 2022-12-01
    “…Abstract Positron emission tomography (PET) as an imaging modality has undergone considerable innovation over the past few decades. …”
    Get full text
    Article
  17. 37

    Elastofibroma Dorsi: Positron Emission Tomography/Computed Tomography Perspective by Tamer Aksoy

    Published 2019-09-01
    “…It can be detected with various imaging modalities, such as computed tomography (CT), magnetic resonance imaging, ultrasonography and positron emission tomography (PET). In this retrospective study, the clinical features of EDs detected in PET/CT examinations performed for malignant or nonmalignant causes were evaluated.Methods:In this retrospective study, PET/CT examinations performed between May 2014 and December 2017 in a single institution for oncological and non-oncological diseases were evaluated retrospectively. …”
    Get full text
    Article
  18. 38
  19. 39
  20. 40

    Measuring the neuromodulatory effects of drugs in man with positron emission tomography. by Friston, K, Grasby, P, Bench, C, Frith, C, Cowen, P, Liddle, P, Frackowiak, R, Dolan, R

    Published 1992
    “…Cognitive activation in conjunction with pharmacological challenge was used to demonstrate neuromodulation in man. Using positron emission tomography (PET), measurements of regional cerebral blood flow were made during the performance of memory tasks, before and after the administration of apomorphine (dopamine agonist), buspirone (5-HT1A partial agonist) or placebo. …”
    Journal article